OVERVIEW
The global market for newborn screening is projected to generate around USD 1,585 million by 2025, rising between 2020 and 2025 at a CAGR of about 11.52%. This high growth is due mainly to the benefits provided by newborn screening services, laws and regulations, technical advancements, policy funding, and growing panel of newborn diseases, as well as conferences and symposia related to the use of new technologies.
TABLE OF CONTENT
1 Global NewBorn Screening Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
3 Global NewBorn Screening Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography
4 Global NewBorn Screening Market – Industry Market Entry Scenario
4.1 Regulatory Framework Overview
4.2 New Business and Ease of Doing business index
4.3 Case studies of successful ventures
4.4 Customer Analysis – Top 10 companies
5 Global NewBorn Screening Market – Market Forces
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.2 Opportunities
5.2.3 Challenges
5.3 Porters Analysis of Market
5.3.1 Bargaining power of suppliers
5.3.2 Bargaining powers of customers
5.3.3 Threat of new entrants
5.3.4 Rivalry among existing players
5.3.5 Threat of substitutes
6 Global NewBorn Screening Market – Strategic Analysis
6.1 Value Chain analysis
6.2 Supplier and distributor analysis (Market share and product dealing strategies)
7 Global NewBorn Screening Market – By Test Type (Market Size – & million/billion)
7.1 Dry Blood Spot Test
7.2 Hearing Screen Test
7.3 Critical Congenital Heart Disease (CCHD) Test
8 Global NewBorn Screening Market – By Product
8.1 Instruments
8.2 Reagents and Assay Kits
9 Global NewBorn Screening Market – By Technology
9.1 Tandem Mass Spectrometry
9.2 Electrophoresis
9.3 Enzymes and Immunoassays
9.4 DNA-based Assays
9.5 Hearing Screen Technology
9.6 Pulse Oximetry Technology
10 Global NewBorn Screening Market – By Geography (Market Size – & million/billion)
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 U.K
10.3.2 Germany
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia-Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 South Korea
10.4.5 Rest of APAC
10.5 Rest of the World
10.5.1 South America
10.5.2 Middle East
10.5.3 Africa
11 Global NewBorn Screening Market – Entropy
11.1 New product launches
11.2 M&A’s, collaborations, JVs and partnerships
12 Global NewBorn Screening Market Company Profile (Key Players)
12.1 Market Share, Company Revenue, Products, M&A, Developments
12.2 AB Sciex LLC (A Subsidiary of Danaher Corporation)
12.3 Agilent Technologies Inc.
12.4 Perkinelmer, Inc.
12.5 Waters Corporation
12.6 Covidien PLC
12.7 GE Healthcare (A Subsidiary of General Electric Company)
12.8 Trivitron Healthcare
12.9 Natus Medical Incorporated
12.10 Masimo Corporation
12.11 Bio-Rad Laboratories, Inc.
12.12 Company 11 & more
13 Global NewBorn Screening Market – Appendix
13.1 Sources
13.2 Abbreviations